144 related articles for article (PubMed ID: 32504188)
1. Cytotoxic T lymphocyte antigen-4 (CTLA-4) expression in chordoma and tumor-infiltrating lymphocytes (TILs) predicts prognosis of spinal chordoma.
He G; Liu X; Pan X; Ma Y; Liu X
Clin Transl Oncol; 2020 Dec; 22(12):2324-2332. PubMed ID: 32504188
[TBL] [Abstract][Full Text] [Related]
2. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients.
Xia C; Huang W; Chen YL; Fu HB; Tang M; Zhang TL; Li J; Lv GH; Yan YG; Ouyang ZH; Yao N; Wang C; Zou MX
Front Immunol; 2021; 12():797407. PubMed ID: 35145510
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic implications of CD8
Zou MX; Guo KM; Lv GH; Huang W; Li J; Wang XB; Jiang Y; She XL
Cancer Immunol Immunother; 2018 Feb; 67(2):209-224. PubMed ID: 29051990
[TBL] [Abstract][Full Text] [Related]
5. Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.
Lim YJ; Koh J; Kim K; Chie EK; Kim S; Lee KB; Jang JY; Kim SW; Oh DY; Bang YJ
Target Oncol; 2017 Apr; 12(2):211-218. PubMed ID: 28084572
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma.
Liu P; Xiao Q; Zhou B; Dai Z; Kang Y
World Neurosurg; 2019 Sep; 129():e240-e254. PubMed ID: 31128313
[TBL] [Abstract][Full Text] [Related]
7. Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma.
Feng Y; Shen J; Gao Y; Liao Y; Cote G; Choy E; Chebib I; Mankin H; Hornicek F; Duan Z
Oncotarget; 2015 May; 6(13):11139-49. PubMed ID: 25871477
[TBL] [Abstract][Full Text] [Related]
8. The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma.
Zou MX; Zheng BW; Liu FS; Wang XB; Hu JR; Huang W; Dai ZH; Zhang QS; Liu FB; Zhong H; Jiang Y; She XL; Li XB; Lv GH; Li J
Neurosurgery; 2019 Dec; 85(6):E1095-E1110. PubMed ID: 31501892
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma.
Abdelrahman DI; Elhasadi I; Anbaig A; Bakry A; Mandour D; Wasefy T; Yehia AM; Alorini M; Shalaby AM; Yahia AIO; Alabiad MA
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):71-83. PubMed ID: 38108390
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer.
Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J
Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological implications of TIM3
Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
[TBL] [Abstract][Full Text] [Related]
12. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of Immune Infiltrates in the Breast Cancer Microenvironment: The Role of Expressions of CTLA-4, PD-1, and LAG-3.
Bagbudar S; Karanlik H; Cabioglu N; Bayram A; Ibis K; Aydin E; Yavuz E; Onder S
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):99-107. PubMed ID: 34608875
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
[TBL] [Abstract][Full Text] [Related]
15. Expression of programmed death-1 ligand (PD-L1) in tumor-infiltrating lymphocytes is associated with favorable spinal chordoma prognosis.
Zou MX; Peng AB; Lv GH; Wang XB; Li J; She XL; Jiang Y
Am J Transl Res; 2016; 8(7):3274-87. PubMed ID: 27508049
[TBL] [Abstract][Full Text] [Related]
16. Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis.
Chen K; Mo J; Zhou M; Wang G; Wu G; Chen H; Zhang K; Yang H
Med Oncol; 2014 Apr; 31(4):886. PubMed ID: 24535608
[TBL] [Abstract][Full Text] [Related]
17. Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?
Zito Marino F; Ascierto PA; Rossi G; Staibano S; Montella M; Russo D; Alfano R; Morabito A; Botti G; Franco R
Expert Opin Biol Ther; 2017 Jun; 17(6):735-746. PubMed ID: 28318336
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.
Akhavan-Sigari R; Gaab MR; Rohde V; Abili M; Ostertag H
Eur Spine J; 2014 Nov; 23(11):2416-22. PubMed ID: 24929808
[TBL] [Abstract][Full Text] [Related]
20. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
